 |
|
A prospective study to assess the efficacy and safety of oral propranolol as first-line treatment for infantile superficial hemangioma
Yeong Ju Yun (Yun YJ), Yun Hee Gyon (Gyon YH), Sohyoung Yang (Yang S), Youn Kyung Lee (Lee YK), Joohyun Park (Park J), Meerim Park (Park M)
Clin Exp Pediatr. 2015;58(12):484-490. Published online 2015 Dec 22 DOI: https://doi.org/10.3345/kjp.2015.58.12.484
|
|
Citations to this article as recorded by
 Propranolol in the Treatment of Infantile Hemangiomas
Xin Tan, Shu Guo, Chenchao Wang
Clinical, Cosmetic and Investigational Dermatology.2021; Volume 14: 1155. CrossRef Infantile Hemangioma: An Updated Review
Alexander K.C. Leung, Joseph M. Lam, Kin F. Leong, Kam L. Hon
Current Pediatric Reviews.2021; 17(1): 55. CrossRef Update on infantile hemangioma
Hye Lim Jung
Clinical and Experimental Pediatrics.2021; 64(11): 559. CrossRef Lip Infantile Hemangiomas Involving the Vermillion Border Have Worse Outcomes and Prognosis to Oral Propranolol Than Lesions Confined to One Side of the Vermillion
Peng Xu, Qian Yu, Huizhen Huang, Wenjie Zhang, Wei Li
Journal of Oral and Maxillofacial Surgery.2020; 78(3): 446. CrossRef The effectiveness and safety of topical β‐receptor blocker in treating superficial infantile haemangiomas: A meta‐analysis including 20 studies
Zhenying Lin, Baoxin Zhang, Zhongjing Yu, Huanyuan Li
British Journal of Clinical Pharmacology.2020; 86(2): 199. CrossRef Serum cytokine profiles in infants with infantile hemangiomas on oral propranolol treatment: VEGF and bFGF, potential biomarkers predicting clinical outcomes
Meerim Park, Hye Lim Jung, Ye Jee Shim, Heung Sik Kim, Hoi Soo Yoon, Sang Kyu Park, Hee Won Cheuh, Mee Jeong Lee, Jae Min Lee, Eun Sil Park, Jae Hee Lee, Yeon-Jung Lim, Young Bae Choi
Pediatric Research.2020; 88(5): 749. CrossRef Associations between short-term efficacy and clinical characteristics of infantile hemangioma treated by propranolol
Changhua Wu, Lei Guo, Liang Wang, Jing Li, Changfeng Wang, Dan Song
Medicine.2019; 98(6): e14346. CrossRef Adrenergic Signaling: A Targetable Checkpoint Limiting Development of the Antitumor Immune Response
Guanxi Qiao, Minhui Chen, Mark J. Bucsek, Elizabeth A. Repasky, Bonnie L. Hylander
Frontiers in Immunology.2018;[Epub] CrossRef Treatment of Facial Infantile Hemangioma: Comparative Study Between Propranolol and Ethanolamine Oleate
Thais Miguel do Monte Lameiro, Rafael Denadai, João Carlos Pereira-Filho, Cesar Augusto Raposo-Amaral, Cassio Eduardo Raposo-Amaral
Journal of Craniofacial Surgery.2018; 29(6): 1514. CrossRef Propranolol inhibits the activity of PI3K, AKT, and HIF-1α in infantile hemangiomas
Zhenying Lin, Luanhong Wang, Guang Huang, Wenyan Wang, Han Lin
Pediatric Surgery International.2018; 34(11): 1233. CrossRef Update March 2016
Francine Blei
Lymphatic Research and Biology.2016; 14(1): 40. CrossRef Update on recent research into infantile hemangioma
Meerim Park
Journal of the Korean Medical Association.2016; 59(9): 698. CrossRef
|